BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 90 filers reported holding BELLICUM PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.58 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $39,000 | -2.5% | 30,448 | -19.7% | 0.00% | – |
| Q3 2019 | $40,000 | -74.5% | 37,906 | -59.1% | 0.00% | -100.0% |
| Q2 2019 | $157,000 | +103.9% | 92,572 | +302.6% | 0.00% | +100.0% |
| Q1 2019 | $77,000 | +8.5% | 22,991 | +111.1% | 0.00% | 0.0% |
| Q1 2018 | $71,000 | -51.7% | 10,893 | +1.0% | 0.00% | -83.3% |
| Q4 2016 | $147,000 | -30.3% | 10,787 | +3.7% | 0.01% | -73.9% |
| Q4 2015 | $211,000 | – | 10,400 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 1,051,441 | $1,356,000 | 0.23% |
| X-Square Capital, LLC | 199,791 | $258,000 | 0.15% |
| Nikko Asset Management Americas, Inc. | 2,300,682 | $2,968,000 | 0.05% |
| SPHERA FUNDS MANAGEMENT LTD. | 400,000 | $516,000 | 0.04% |
| Baker Brothers Advisors | 2,677,818 | $3,454,000 | 0.02% |
| SHUFRO ROSE & CO LLC | 129,417 | $167,000 | 0.02% |
| ARK Investment Management | 417,433 | $538,000 | 0.01% |
| ALGERT GLOBAL LLC | 36,806 | $47,000 | 0.01% |
| OXFORD ASSET MANAGEMENT LLP | 352,465 | $455,000 | 0.01% |
| GSA CAPITAL PARTNERS LLP | 66,472 | $86,000 | 0.01% |